Ftse Mib
36.335,74
-0,10%
DAX
21.687,99
0,30%
S&P 500
6.039,31
-0,47%
NASDAQ
19.632,32
-0,51%
Bitcoin
105.299,99
1,51%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Traws Pharma Inc (TRAW) Traws Pharma Inc (TRAW) Notizie

Traws Pharma Inc

TRAW
7,38
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/1/202501:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/1/202501:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/1/202501:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202522:15EDGAR2Form PRE 14A - Other preliminary proxy statements
23/1/202513:00EDGAR2Form 8-K - Current report
23/1/202513:00PRNUSTraws Pharma Announces Completion of Phase I Studies with..
23/1/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
15/1/202512:33EDGAR2Form S-3 - Registration statement under Securities Act of..
10/1/202523:55PRNUSExpert Systems and Traws Pharma Report Breakthrough in..
31/12/202423:23EDGAR2Form 8-K - Current report
31/12/202423:23EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
30/12/202414:00PRNUSTraws Pharma, Inc. Announces Financing up to $72.6 Million..
23/12/202413:00PRNUSTraws Pharma Announces Progress in Developing Tivoxavir..
20/12/202423:00EDGAR2Form 8-K - Current report
22/11/202423:00EDGAR2Form 8-K - Current report
15/11/202422:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202422:40EDGAR2Form 8-K - Current report
01/11/202422:15EDGAR2Form 8-K - Current report
11/10/202414:46EDGAR2Form DEF 14A - Other definitive proxy statements
27/9/202423:10EDGAR2Form 8-K - Current report
17/9/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/9/202423:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/9/202423:06EDGAR2Form 8-K - Current report
30/8/202412:02EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/8/202423:15EDGAR2Form 8-K - Current report
15/8/202413:30EDGAR2Form 8-K - Current report
15/8/202412:03EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
09/8/202412:00EDGAR2Form DEF 14A - Other definitive proxy statements
30/7/202421:14EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
19/7/202422:01EDGAR2Form 8-K - Current report
17/6/202423:20EDGAR2Form 8-K/A - Current report: [Amend]
22/5/202423:25EDGAR2Form 8-K - Current report
16/5/202422:19EDGAR2Form 8-K - Current report
15/5/202423:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: Min: Max:
Chiusura: 7,38

La tua Cronologia

NASDAQ
TRAW
Traws Pharma
USOTC
CMEY
cMoney (CE)
BIT
I10191
XS2847641615 20280731 58...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci